FDA ANDA · ANDA085499

POTASSIUM CHLORIDE

Sponsor: BAXTER HLTHCARE

APPLICATION

ANDA085499

TYPE

ANDA

ORIGINAL APPROVAL

1977-10-13

LATEST ACTION

2003-09-15

ROUTE

INJECTION

DOSAGE FORM

INJECTABLE

MARKETING STATUS

Discontinued

Products

POTASSIUM CHLORIDEDiscontinued

POTASSIUM CHLORIDE 2MEQ/ML · INJECTABLE · INJECTION

2003-09-15Labeling · Supplement 14AP

1994-10-17Manufacturing (CMC) · Supplement 12AP

1992-05-28Labeling · Supplement 11AP

1991-10-23Labeling · Supplement 10AP

1991-05-16Manufacturing (CMC) · Supplement 9AP

1991-03-22Manufacturing (CMC) · Supplement 8AP

1991-02-08Labeling · Supplement 7AP

1989-01-13Manufacturing (CMC) · Supplement 4AP

1989-01-13Manufacturing (CMC) · Supplement 3AP

1987-04-16Manufacturing (CMC) · Supplement 2AP

1977-10-13OriginalAP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.